Replication and drug resistant mutation of HIV-1 subtype B' (Thailand B) variants isolated from HAART treatment individuals in China

Virology Journal

Volumn 6, Issue , 2009, Pages

  Sun, Jianping ^a,b   Ma, Liying ^a   Yu, Xiaoling ^a,c   Huang, Yang ^a   Yuan, Lin ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL RESISTANCE; ARTICLE; CHINA; COCULTURE; CONTROLLED STUDY; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURAL GENE; VIRUS ISOLATION; VIRUS REPLICATION; ADULT; CELL CULTURE; DRUG EFFECT; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MUTATION; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELLS, CULTURED; CHINA; DRUG RESISTANCE, VIRAL; FEMALE; HIV-1; HUMANS; MALE; MUTATION; VIRUS REPLICATION;

EID: 74949085440     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-201     Document Type: Article

References (25)

1. HIV chemotherapy. DD Richman, Nature 2001 410 995 1001 10.1038/35073673 11309630
2. Short communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naive patients in Greenland. TV Madsen N Lohse ES Jensen N Obel K Ladefoged J Gerstoft AB Petersen C Nielsen LB Jorgensen, AIDS Res Hum Retroviruses 2008 24 1073 1077 10.1089/aid.2008.0049 18620490
3. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. SJ Little SD Frost JK Wong DM Smith SL Pond CC Ignacio NT Parkin CJ Petropoulos DD Richman, J Virol 2008 82 5510 5518 10.1128/JVI.02579-07 18353964
4. Polymorphism of the protease and reverse transcriptase and drug resistance mutation patterns of HIV-1 subtype B prevailing in China. S Jiang H Xing X Si Y Wang Y Shao, J Acquir Immune Defic Syndr 2006 42 512 514 10.1097/01.qai.0000221688.69596.ba 16810118
5. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation. M Zhang XX Han WG Cui MH Jia XD Meng AH Xing YH Wu YY Yang CM Lu QH Hu D Dai ZN Zhang H Shang, Jpn J Infect Dis 2008 61 361 365 18806342
6. Genotype and phenotype patterns of drug-resistant HIV-1 subtype B' (Thai B) isolated from patients failing antiretroviral therapy in China. L Ma J Sun H Xing X Si L Yuan Y Guo H Cheng Y Shao, J Acquir Immune Defic Syndr 2007 44 14 19 10.1097/01.qai.0000243049.27580.cc 17019361
7. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. A Morner A Bjorndal J Albert VN Kewalramani DR Littman R Inoue R Thorstensson EM Fenyo E Bjorling, J Virol 1999 73 2343 2349 9971817
8. Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay. D Vodros C Tscherning-Casper L Navea D Schols E De Clercq EM Fenyo, Virology 2001 291 1 11 10.1006/viro.2001.1163 11878871
9. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. M Peeters F Liegeois N Torimiro A Bourgeois E Mpoudi L Vergne E Saman E Delaporte S Saragosti, J Virol 1999 73 7368 7375 10438826
10. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. T Dragic V Litwin GP Allaway SR Martin Y Huang KA Nagashima C Cayanan PJ Maddon RA Koup JP Moore WA Paxton, Nature 1996 381 667 673 10.1038/381667a0 8649512
11. Identification of a major co-receptor for primary isolates of HIV-1. H Deng R Liu W Ellmeier S Choe D Unutmaz M Burkhart P Di Marzio S Marmon RE Sutton CM Hill CB Davis SC Peiper TJ Schall DR Littman NR Landau, Nature 1996 381 661 666 10.1038/381661a0 8649511
12. HIV-1 subtype and second-receptor use. L Zhang Y Huang T He Y Cao DD Ho, Nature 1996 383 768 10.1038/383768a0 8892998
13. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Y Feng CC Broder PE Kennedy EA Berger, Science 1996 272 872 877 10.1126/science.272.5263.872 8629022
14. FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist. AIDS Alert 2007 22 103
15. R5 to X4 coreceptor switch of human immunodeficiency virus type 1 B' and B'/C recombinant subtype isolates in China. YF Guo LY Ma L Yuan SH Wang JP Sun WS Xu JQ Xu H Xing KX Ong XY Zhang YH Ruan YX Zhang YM Shao, Chin Med J (Engl) 2007 120 522 525 17439749
16. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. S Glushakova JC Grivel W Fitzgerald A Sylwester J Zimmerberg LB Margolis, Nat Med 1998 4 346 349 10.1038/nm0398-346 9500611
17. Human immunodeficiency virus type 1 (HIV-1) non-B subtypes are similar to HIV-1 subtype B in that coreceptor specificity is a determinant of cytopathicity in human lymphoid tissue infected ex vivo. N Malkevich C Womack P Pandya JC Grivel AS Fauci L Margolis, J Virol 2001 75 10520 10522 10.1128/JVI.75.21.10520-10522.2001 11581424
18. Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection. V Simon N Padte D Murray J Vanderhoeven T Wrin N Parkin M Di Mascio M Markowitz, J Virol 2003 77 7736 7745 10.1128/JVI.77.14.7736-7745.2003 12829813
19. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. E Nicastri L Sarmati G d'Ettorre L Palmisano SG Parisi I Uccella A Rianda E Concia V Vullo S Vella M Andreoni, J Med Virol 2003 69 1 6 10.1002/jmv.10269 12436471
20. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. DR Bangsberg EP Acosta R Gupta D Guzman ED Riley PR Harrigan N Parkin SG Deeks, Aids 2006 20 223 231 10.1097/01.aids.0000199825.34241.49 16511415
21. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society-USA Panel. MS Hirsch B Conway RT D'Aquila VA Johnson F Brun-Vezinet B Clotet LM Demeter SM Hammer DM Jacobsen DR Kuritzkes C Loveday JW Mellors S Vella DD Richman, Jama 1998 279 1984 1991 10.1001/jama.279.24.1984 9643863
22. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. SG Deeks T Wrin T Liegler R Hoh M Hayden JD Barbour NS Hellmann CJ Petropoulos JM McCune MK Hellerstein RM Grant, N Engl J Med 2001 344 472 480 10.1056/NEJM200102153440702 11172188
23. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. S Yerly A Rakik SK De Loes B Hirschel D Descamps F Brun-Vezinet L Perrin, J Virol 1998 72 3520 3523 9557630
24. Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. AJ Hance V Lemiale J Izopet D Lecossier V Joly P Massip F Mammano D Descamps F Brun-Vezinet F Clavel, J Virol 2001 75 6410 6417 10.1128/JVI.75.14.6410-6417.2001 11413308
25. HIV drug resistance and viral fitness. F Clavel E Race F Mammano, Adv Pharmacol 2000 49 41 66 full-text 11013760